<!DOCTYPE html>
<html lang="en">
<head>
<title>Coronavirus Infection (COVID-19)</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
<link rel="stylesheet" type="text/css" href="../../../public/css/offline.css" />
<script src="../../../public/javascripts/jquery-1.10.2.min.js"></script>
</head>
<body class="dsg-wb">

<table width="80%" class="offline">
<tr>
  <td colspan="3" class="header"><h1><a href="/">JPAC</a> <span>Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee</span></h1></td>
</tr>
<tr class="tabs">
  <td colspan="3">
              <ul>
                  <li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components"><a href="../../../dsg/wb/guidelines.html"  class="active">Whole Blood and Components</a></li>
                  <li id="ddb09bf2-3dc0-4eb2-ba57-a5db69331dd1" class="geographical-disease-risk-index"><a href="../../../dsg/gdri/guidelines.html" >Geographical Disease Risk Index</a></li>
                </ul>
        </td>
</tr>
<tr>
  <td class="spacerow" colspan="3"></td>
</tr>
<tr>
  <td class="sidebar" width="25%">
    <div class="well">
          <ul class="openContentSectionWithSubs sidebarTopHeader"><li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components sectionHead first last"><a href="../../../dsg/wb.html">Whole Blood and Components</a>
<ul class="">
<li id="42be2de8-89aa-4908-8bc8-702f9e636a81" class="a-z-search active first"><a href="../../../dsg/wb/guidelines.html">A-Z Search</a>
</li><li id="1f7e1f13-8b29-4772-ae9d-2b5cc3d59491" class="updates"><a href="../../../dsg/wb/latest-updates.html">Updates</a>
</li><li id="f83d68fb-19de-4588-9a36-a8bba0aa6494" class="drug-index"><a href="../../../dsg/wb/drug-index.html">Drug Index</a>

</li><li id="769da873-1c35-4600-8be8-d2df902570a0" class="preliminaries"><a href="../../../dsg/wb/preliminaries.html">Preliminaries</a>
<ul class="">
<li id="258895c3-f3dd-45c6-932c-3fe4795870c2" class="introduction first"><a href="../../../dsg/wb/preliminaries/introduction.html">Introduction</a>
</li><li id="ef298454-8327-4f6c-9f4a-835e437df103" class="document-and-change-control"><a href="../../../dsg/wb/preliminaries/document-and-change-control.html">Document and Change Control</a>
</li><li id="093e6463-a089-49dd-9199-c8f92559f486" class="general-principles"><a href="../../../dsg/wb/preliminaries/general-principles.html">General Principles</a>
</li><li id="96f75c3a-2c62-445b-847c-353098eaec1e" class="medication"><a href="../../../dsg/wb/preliminaries/medication.html">Medication</a>
</li><li id="ed51942d-a7fd-42f7-8269-d23b879f99ca" class="inspection-of-the-donor"><a href="../../../dsg/wb/preliminaries/inspection-of-the-donor.html">Inspection of the Donor</a>
</li><li id="99af8b5e-491b-4d67-b69a-812d81af4d7d" class="use-of-alphabetical-listing last"><a href="../../../dsg/wb/preliminaries/use-of-alphabetical-listing.html">Use of Alphabetical Listing</a>
</li></ul>
</li><li id="753eb36f-2636-414c-84ee-1004e197502d" class="appendices"><a href="../../../dsg/wb/appendicies.html">Appendices</a>
<ul class="">
<li id="e147bd96-a025-4ffa-b530-b9abefc27043" class="appendix-1---estimated-blood-volume-for-female-donors-after-nadler--by-height-and-weight first"><a href="../../../dsg/wb/appendicies/appendix-1.html">Appendix 1 - Estimated Blood Volume for Female donors (after Nadler)  by height and weight</a>
</li><li id="2f1eca54-e34f-4ece-90a4-7dfe0f210c8d" class="appendix-2---table-of-immunisations-"><a href="../../../dsg/wb/appendicies/appendix-2-table-of-immunizations.html">Appendix 2 - Table of Immunisations </a>
</li><li id="a27f8ce9-b4f6-4a9b-baf0-6f655955a9aa" class="appendix-3---maximum-permitted-ecv-for-component-donors"><a href="../../../dsg/wb/appendicies/appendix-3-maximum-permitted-extra-corporeal-volume-for-component-donors.html">Appendix 3 - Maximum permitted ECV for component donors</a>
</li><li id="90c869cb-7256-4604-8699-d8a86f78aa26" class="appendix-4---management-of-post-donation-illness last"><a href="../../../dsg/wb/appendicies/appendix-4-management-of-post-donation-illness.html">Appendix 4 - Management of post donation illness</a>
</li></ul>
</li><li id="b62a2d12-6d94-4106-92a8-1de426a4b863" class="source-files last"><a href="../../../dsg/wb/source-files.html">Source Files</a>
</li></ul>
</li></ul>
    </div>
  </td>
  <td width="5%"></td>
  <td width="70%" class="content">
    <h2>Coronavirus Infection (COVID-19)</h2>    

<table class="data-table"><tbody><tr class="data-row"><td class="data-label">Includes</td><td class="data-value"><p>COVID-19 disease due to infection with SARS-CoV-2 virus, previously known as Novel Coronavirus or 2019-nCoV.</p></td></tr><tr class="data-row"><td class="data-label">Definitions</td><td class="data-value"><p><strong>Testing:</strong> PCR (polymerase chain reaction) and rapid lateral flow tests (LFTs), usually by throat and/or nose swab, to detect the presence of SARS-CoV-2. This does not include testing for antibodies to SARS-CoV-2</p></td></tr><tr><td class="data-sub" colspan="2"><table class="data-sub-table"><tbody><tr><td class="data-header" colspan="2"> 1.	 Individuals with confirmed or suspected COVID-19 infection</td></tr><tr class="data-row"><td class="data-label">Includes</td><td class="data-value"><ul>
	<li>Individuals with confirmed COVID-19 infection, diagnosed by a positive LFT or PCR test.</li>
	<li>Individuals where the results of SARS-Cov-2 testing, if carried out at the request of a health care professional, are awaited.</li>
</ul></td></tr><tr class="data-row"><td class="data-label">Obligatory</td><td class="data-value"><p><strong>Must not donate.</strong></p></td></tr><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><p>If it is at least seven days from the resolution of symptoms, and no further testing is required, accept.</p></td></tr></tbody></table></td></tr><tr><td class="data-sub" colspan="2"><table class="data-sub-table"><tbody><tr><td class="data-header" colspan="2">2. Individuals with non-specific symptoms, not confirmed as COVID-19</td></tr><tr class="data-row"><td class="data-label">Includes</td><td class="data-value"><p>Individuals who have non-specific symptoms of a respiratory infection, including coughs and cold symptoms.</p></td></tr><tr class="data-row"><td class="data-label">Excludes</td><td class="data-value"><p>Individuals who are awaiting test results for SARS-CoV-2 infection, as requested by a health care professional.</p></td></tr><tr class="data-row"><td class="data-label">Obligatory</td><td class="data-value"><p>See <a href="../../../dsg/wb/guidelines/in003-infection-acute.html">Infection - Acute</a></p></td></tr></tbody></table></td></tr><tr><td class="data-sub" colspan="2"><table class="data-sub-table"><tbody><tr><td class="data-header" colspan="2"> 3. Post-Covid Syndrome (Long Covid)</td></tr><tr class="data-row"><td class="data-label">Obligatory</td><td class="data-value"><p><strong>Must not donate</strong></p></td></tr><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><p>If it is at least 6 months since all symptoms, including fatigue, have resolved, accept.</p></td></tr></tbody></table></td></tr><tr><td class="data-sub" colspan="2"><table class="data-sub-table"><tbody><tr><td class="data-header" colspan="2">4. Occupational and other routine surveillance</td></tr><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><p>Donors who have regular testing for the presence of SARS-CoV-2 (Coronavirus) can be accepted to donate provided they have not had a positive test for SARS-CoV-2 in the last seven days.<br />
<br />
This includes donors who work in a Health, Social Care or Educational setting.</p></td></tr></tbody></table></td></tr><tr class="data-row"><td class="data-label">See if Relevant</td><td class="data-value"><p><a href="../../../dsg/wb/guidelines/clinical-trials.html">Clinical Trials</a><br />
<a href="../../../dsg/wb/guidelines/im003-immunization-non-live.html">Immunisation &#8211; Non-live</a><br />
<a href="../../../dsg/wb/guidelines/in003-infection-acute.html">Infection - Acute</a></p></td></tr><tr class="data-row"><td class="data-label">Additional Information</td><td class="data-value"><p>Common coronaviruses cause colds and respiratory tract infections but are not considered a risk for transfusion recipients. Since 2002 there have been outbreaks in humans of new strains of coronavirus, associated with severe pulmonary infections and mortality rates of 10-35% e.g. SARS and MERS.<br />
<br />
COVID-19 is an illness caused by infection with SARS-CoV-2, a new coronavirus first identified in 2019. The guidance within this entry is focussed on COVID-19. Donors who report MERS or SARS, or contact with these infections, should be referred to a DCSO.<br />
<br />
Many respiratory illnesses, including COVID-19, share common symptoms. As routine testing for SARS-CoV-2 infection is no longer recommended, most individuals will not have test results to confirm or exclude COVID-19. Where COVID-19 testing is not being undertaken, assessing donors using the Infection &#8211; Acute entry ensures that individuals are deferred for the appropriate time based on their symptoms.<br />
<br />
Individuals affected by COVID-19 may experience longer term symptoms. Post-Covid Syndrome (PCS), which may also be known as Long Covid, is recognised in individuals who have persistent symptoms for 12 weeks or more. PCS is a multisystem disease; common symptoms include fatigue, breathlessness and ‘brain fog’. Affected individuals may also experience cardiac, musculoskeletal, gastrointestinal and neurological symptoms. As PCS may follow a relapsing course, it is important individuals have fully recovered before being accepted to donate.</p></td></tr><tr class="data-row"><td class="data-label">Post Donation Information</td><td class="data-value"><p>There is no evidence at present that coronaviruses can be transmitted by blood transfusion and therefore these measures are precautionary.&nbsp;</p>


<p><br />
Donors must be provided with information about contacting the blood service if they develop any illness after blood or component donation.</p>



<p><br />
If a donor reports post-donation respiratory illness, refer to <a href="../../../dsg/wb/appendicies/appendix-4-management-of-post-donation-illness.html">Appendix 4 &#8211; Management of post donation illness</a></p></td></tr><tr class="data-row"><td class="data-label">Reason for change</td><td class="data-value"><p>The deferral after COVID-19 vaccination has been removed.</p></td></tr></tbody></table>
<div class="pull-right attachments"><div class="cms images">
  
</div></div>

  
<dl class="update-information"><dt class="data-label"><h4>Update Information</h4></dt><dd class="data-value"><p>This entry was last updated in:<br />
WB-DSG&nbsp;Edition 203&nbsp;Release 74</p></dd></dl>  </td>
</tr>
</table>
</body>
</html>